Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

MOMIPP

🥰Excellent
Catalog No. T33467Cas No. 1363421-46-8

MOMIPP is a PIKfyve inhibitor and a macropinocytosis inducer. MOMIPP readily penetrates the blood-brain barrier and is moderately effective in suppressing progression of intracerebral glioblastoma xenografts[1][2].

MOMIPP

MOMIPP

🥰Excellent
Purity: 99.66%
Catalog No. T33467Cas No. 1363421-46-8
MOMIPP is a PIKfyve inhibitor and a macropinocytosis inducer. MOMIPP readily penetrates the blood-brain barrier and is moderately effective in suppressing progression of intracerebral glioblastoma xenografts[1][2].
Pack SizePriceAvailabilityQuantity
1 mg$116In Stock
5 mg$163In Stock
10 mg$263In Stock
25 mg$479In Stock
50 mg$662In Stock
100 mg$993In Stock
1 mL x 10 mM (in DMSO)$258In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "MOMIPP"

Select Batch
Purity:99.66%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
MOMIPP is a PIKfyve inhibitor and a macropinocytosis inducer. MOMIPP readily penetrates the blood-brain barrier and is moderately effective in suppressing progression of intracerebral glioblastoma xenografts[1][2].
In vitro
MOMIPP can induce intense macropinocytosis, leading to methuosis in cultured glioblastoma cells at low micromolar concentrations[1]. MOMIPP(3 μM) induces cell vacuolization in U373 and Hs683 cell lines[1]. The cytotoxic IPP compound, MOMIPP, causes early disruptions of glucose uptake and glycolytic metabolism. Coincident with these metabolic changes, MOMIPP selectively activates the JNK1/2 stress kinase pathway, resulting in phosphorylation of c-Jun, Bcl-2 and Bcl-xL[2].
In vivo
MOMIPP (80 mg/kg; i.p.; once daily; for 15 consecutive days) shows result that MOMIPP is moderately effective in suppressing progression of intracerebral glioblastoma xenografts.
Cell Research
When JNK activation (phosphorylation) was assessed by western blot analysis after 24 h, MOMIPP(10 μM)has been found that induced major increases in JNK1/2 phosphorylation[2].
Animal Research
MOMIPP (Athymic CrTac:NCR-Foxn1 mice (female, 7-8 weeks); 80 mg/kg; i.p.; once daily; for 15 consecutive days) suppressed progression of intracerebral glioblastoma xenografts[2].
Chemical Properties
Molecular Weight292.33
FormulaC18H16N2O2
Cas No.1363421-46-8
SmilesCOc1ccc2[nH]c(C)c(\C=C\C(=O)c3ccncc3)c2c1
Relative Density.1.239 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 15.13 mg/mL (51.74 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.4208 mL17.1040 mL34.2079 mL171.0396 mL
5 mM0.6842 mL3.4208 mL6.8416 mL34.2079 mL
10 mM0.3421 mL1.7104 mL3.4208 mL17.1040 mL
20 mM0.1710 mL0.8552 mL1.7104 mL8.5520 mL
50 mM0.0684 mL0.3421 mL0.6842 mL3.4208 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy MOMIPP | purchase MOMIPP | MOMIPP cost | order MOMIPP | MOMIPP chemical structure | MOMIPP in vivo | MOMIPP in vitro | MOMIPP formula | MOMIPP molecular weight